$0.36
5.85% yesterday
Nasdaq, Apr 04, 10:10 pm CET
ISIN
CA45257F2008
Symbol
IPA
Sector
Industry

ImmunoPrecise Antibodies Ltd Stock price

$0.36
+0.01 2.07% 1M
-0.27 42.42% 6M
-0.05 12.58% YTD
-1.09 75.18% 1Y
-5.32 93.66% 3Y
-2.45 87.21% 5Y
+0.25 242.76% 10Y
Nasdaq, Closing price Fri, Apr 04 2025
+0.02 5.85%
ISIN
CA45257F2008
Symbol
IPA
Sector
Industry

Key metrics

Market capitalization $8.97m
Enterprise Value $8.98m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.52
P/S ratio (TTM) P/S ratio 0.51
P/B ratio (TTM) P/B ratio 0.95
Revenue growth (TTM) Revenue growth -0.71%
Revenue (TTM) Revenue $17.42m
EBIT (operating result TTM) EBIT $-10.49m
Free Cash Flow (TTM) Free Cash Flow $-6.79m
Cash position $8.92m
EPS (TTM) EPS $-1.13
P/S forward 0.50
EV/Sales forward 0.51
Short interest 6.67%
Show more

Is ImmunoPrecise Antibodies Ltd a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

ImmunoPrecise Antibodies Ltd Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a ImmunoPrecise Antibodies Ltd forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a ImmunoPrecise Antibodies Ltd forecast:

Buy
100%

Financial data from ImmunoPrecise Antibodies Ltd

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jan '25
+/-
%
17 17
1% 1%
100%
- Direct Costs 10 10
6% 6%
60%
7 7
9% 9%
40%
- Selling and Administrative Expenses 9.82 9.82
18% 18%
56%
- Research and Development Expense 3.47 3.47
57% 57%
20%
-6.29 -6.29
19% 19%
-36%
- Depreciation and Amortization 4.20 4.20
8% 8%
24%
EBIT (Operating Income) EBIT -10 -10
15% 15%
-60%
Net Profit -33 -33
215% 215%
-191%

In millions USD.

Don't miss a Thing! We will send you all news about ImmunoPrecise Antibodies Ltd directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ImmunoPrecise Antibodies Ltd Stock News

Neutral
Seeking Alpha
8 days ago
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA ) Q3 2025 Earnings Conference Call March 28, 2025 10:30 AM ET Company Participants Jennifer Bath - Chief Executive Officer and President Joseph Scheffler - Interim Chief Financial Officer Conference Call Participants Swayampakula Ramakanth - H.C.
Neutral
Business Wire
8 days ago
AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today reported financial results for the third quarter (“Q3”) of its 2025 fiscal year (“FY25”), which ended January 31, 2025. "As we continue to revolutionize the AI-enabled drug discovery sector, our recent milestones un...
Neutral
Business Wire
23 days ago
AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) is pleased to announce a strategic partnership with a leading biotechnology company with a multi-billion-dollar market capitalization to advance the discovery and development of Antibody-Drug Conjugates (ADCs) and bispecific antibodies for the treatment of cancer. This collaboration focuses on leverag...
More ImmunoPrecise Antibodies Ltd News

Company Profile

ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The firm offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.

Head office Canada
CEO Jennifer Bath
Employees 101
Founded 1983
Website www.ipatherapeutics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today